References
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel
coronavirus from patients with pneumonia in China, 2019. New England
journal of medicine. 2020.
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features
of patients infected with 2019 novel coronavirus in Wuhan, China. The
lancet. 2020;395(10223):497-506.
3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirus-Infected Pneumonia in Wuhan, China. Jama.
2020;323(11):1061-9.
4. Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary
study to identify severe from moderate cases of COVID-19 using combined
hematology parameters. Annals of translational medicine. 2020;8(9).
5. Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y-Q, et al. Lymphopenia
predicts disease severity of COVID-19: a descriptive and predictive
study. Signal transduction and targeted therapy. 2020;5(1):1-3.
6. BAKANLIĞI TS. COVID-19 (SARS-CoV2 ENFEKSİYONU) REHBERİ. Erişim:https://covid19bilgi saglik gov
tr/depo/rehberler/COVID-19_Rehberi pdf (Erişim Tarihi: 1607 2020).
2020.
7. Yang A-P, Liu J-P, Tao W-Q, Li H-m. The diagnostic and predictive
role of NLR, d-NLR and PLR in COVID-19 patients. International
immunopharmacology. 2020;84:106504.
8. Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy,
Journal.(2020). 2020.
9. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological
and clinical characteristics of 99 cases of 2019 novel coronavirus
pneumonia in Wuhan, China: a descriptive study. The lancet.
2020;395(10223):507-13.
10. Wong RS, Wu A, To K, Lee N, Lam CW, Wong C, et al. Haematological
manifestations in patients with severe acute respiratory syndrome:
retrospective analysis. Bmj. 2003;326(7403):1358-62.
11. Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. The
Lancet Respiratory Medicine. 2020;8(4):e24.
12. Fan BE. Hematologic parameters in patients with COVID‐19 infection:
a reply. American journal of hematology. 2020.
13. Xu Y, Zhang Y, Jiang F, Zheng H, Pang G, Yang L, et al. Comparison
of relevant indicators of coagulation and fibrinolysis in patients with
varying severity of community-acquired pneumonia. Zhonghua yi xue za
zhi. 2015;95(24):1925-9.
14. Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN,
et al. Diagnostic and prognostic value of hematological and
immunological markers in COVID-19 infection: A meta-analysis of 6320
patients. PloS one. 2020;15(8):e0238160.
15. Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G.
Hematologic, biochemical and immune biomarker abnormalities associated
with severe illness and mortality in coronavirus disease 2019
(COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine
(CCLM). 2020;58(7):1021-8.